Funding
The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient support organisations for allergy in Australia, developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. ASCIA and A&AA greatly appreciate the funding support that has enabled the development and initial implementation of the National Allergy Strategy.
The National Allergy Strategy has now transitioned to become the National Allergy Council, and continues to implement the National Allergy Strategy alongside ASCIA and A&AA.
The National Allergy Council has received funding from the Australian Government Department of Health from 1 July 2022 to 30 June 2026, to progress the implementation of the National Allergy Strategy in response to the Parliamentary Inquiry into Allergies and Anaphylaxis which led to the Walking the allergy tightrope report. This funding also includes funding provision for the National Allergy Council partner organisations - ASCIA and A&AA.
The Australian Government's response to the Walking the allergy tightrope report was tabled in Parliament in April 2023.
For more information about the project work being undertaken by the National Allergy Council, visit our project webpages.
Development of the National Allergy Strategy
While funding from the Australian Government Department of Health has supported implementation since 2015, development of the National Allergy Strategy, including two Allergy Summits was funded by unrestricted education grants obtained by ASCIA. These grants were from the following organisations:
Major supporters:
Mylan (formerly Alphapharm)
Seqirus (formerly bioCSL)
Stallergenes Greer
Bayer
Other supporters:
Nutricia
Nestlé Nutrition
Merck Sharp & Dohme
It is important to note that the content of both the Allergy Summits and the National Allergy Strategy has been independently developed and has not been influenced by organisations that have provided unrestricted educational grants.
Implementation of the National Allergy Strategy
Government funding
Australian Government Department of Health
Australian Digital Health Agency
Unrestricted education grants
The following organisations provided unrestricted education grants to help implement the National Allergy Strategy projects:
Major supporters:
PCH Foundation
GSK
Mylan
Sanofi
Abbott
Allergy Concepts
Nutricia
Bayer
Other supporters:
DBV Technologies
Stallergenes Greer
Abacus dx
Nestle Nutrition
It is important to note that the implementation of the National Allergy Strategy has not been influenced by organisations that have provided unrestricted educational grants.
Private donations
The National Allergy Strategy has received private donations from families and ASCIA members to help implement the National Allergy Strategy
Content updated July 2025